• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

三尖瓣反流与左心疾病所致心力衰竭患者死亡率的关联

Association of Tricuspid Regurgitation With Mortality in Heart Failure With Left-Sided Heart Disease.

作者信息

Kitamura Mitsunobu, Amami Kazuaki, Yaguchi Tomoyuki, Okabe Kouya, Shiraishi Yasuyuki, Nakamaru Ryo, Nagatomo Yuji, Goda Ayumi, Nomoto Michiru, Mizuno Atsushi, Sakamoto Munehisa, Ichihara Yumiko K, Kohno Takashi, Kohsaka Shun, Yoshikawa Tsutomu

机构信息

Department of Cardiology, Sakakibara Heart Institute, Tokyo, Japan.

Department of Cardiology, Sakakibara Heart Institute, Tokyo, Japan.

出版信息

JACC Adv. 2025 May 26;4(6 Pt 1):101832. doi: 10.1016/j.jacadv.2025.101832.

DOI:10.1016/j.jacadv.2025.101832
PMID:40424674
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC12155599/
Abstract

BACKGROUND

Left-sided heart disease is the leading etiology of tricuspid regurgitation (TR) in heart failure (HF); however, the association between different HF phenotypes and the adverse effects of TR remains unclear.

OBJECTIVES

The authors aimed to elucidate the association between TR and outcomes across the subtypes of left-sided heart disease in patients hospitalized for HF.

METHODS

We analyzed data from the multicenter West Tokyo Heart Failure registry between January 2006 and December 2021. Moderate or severe mitral or aortic valve disease was defined as left-sided valve dysfunction (LVD). Patients with congenital heart disease, secondary cardiomyopathy, systemic conditions related to HF, or those with incomplete datasets were excluded. Using a multivariable Cox hazard model, the survival effect of TR on mortality in patients with LVD was examined.

RESULTS

Overall, 3,040 presented with LVD (median age, 80 years; 45.9% female), and 2,438 had no LVD (median age, 74 years; 27.8% female). The prevalence of moderate and severe TR was 27.6% and 6.5% in patients with LVD and 9.2% and 1.5% in those without LVD, respectively. The adjusted HRs of moderate and severe TR for mortality were 1.25 (95% CI: 1.03-1.52) and 1.72 (95% CI: 1.30-2.29) in those with LVD, respectively, and 2.15 (95% CI: 1.62-2.84) and 3.09 (95% CI: 1.87-5.09) in those without LVD, respectively. Significant interactions between the subtypes were observed (P = 0.005).

CONCLUSIONS

TR severity stratified mortality after acute decompensated HF better in patients without LVD than in those with LVD.

摘要

背景

在心力衰竭(HF)中,左侧心脏病是三尖瓣反流(TR)的主要病因;然而,不同HF表型与TR不良影响之间的关联仍不清楚。

目的

作者旨在阐明因HF住院患者中TR与左侧心脏病各亚型预后之间的关联。

方法

我们分析了2006年1月至2021年12月期间多中心东京西部心力衰竭登记处的数据。中度或重度二尖瓣或主动脉瓣疾病被定义为左侧瓣膜功能障碍(LVD)。排除患有先天性心脏病、继发性心肌病、与HF相关的全身性疾病或数据集不完整的患者。使用多变量Cox风险模型,研究TR对LVD患者死亡率的生存影响。

结果

总体而言,3040例有LVD(中位年龄80岁;45.9%为女性),2438例无LVD(中位年龄74岁;27.8%为女性)。有LVD患者中中度和重度TR的患病率分别为27.6%和6.5%,无LVD患者中分别为9.2%和1.5%。有LVD患者中,中度和重度TR死亡的校正风险比分别为1.25(95%CI:1.03 - 1.52)和1.72(95%CI:1.30 - 2.29),无LVD患者中分别为2.15(95%CI:1.62 - 2.84)和3.09(95%CI:1.87 - 5.09)。观察到各亚型之间存在显著交互作用(P = 0.005)。

结论

与有LVD的患者相比,TR严重程度在无LVD的急性失代偿性HF患者中对死亡率的分层效果更好。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bfc9/12155599/ae65c8dd1355/gr7.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bfc9/12155599/ae65c8dd1355/ga1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bfc9/12155599/2efb07b47d34/gr1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bfc9/12155599/9be6539f76f3/gr2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bfc9/12155599/e63962d2e063/gr3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bfc9/12155599/c25612e09f92/gr4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bfc9/12155599/771cafd9821d/gr5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bfc9/12155599/d962f2a82c66/gr6.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bfc9/12155599/ae65c8dd1355/gr7.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bfc9/12155599/ae65c8dd1355/ga1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bfc9/12155599/2efb07b47d34/gr1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bfc9/12155599/9be6539f76f3/gr2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bfc9/12155599/e63962d2e063/gr3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bfc9/12155599/c25612e09f92/gr4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bfc9/12155599/771cafd9821d/gr5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bfc9/12155599/d962f2a82c66/gr6.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bfc9/12155599/ae65c8dd1355/gr7.jpg

相似文献

1
Association of Tricuspid Regurgitation With Mortality in Heart Failure With Left-Sided Heart Disease.三尖瓣反流与左心疾病所致心力衰竭患者死亡率的关联
JACC Adv. 2025 May 26;4(6 Pt 1):101832. doi: 10.1016/j.jacadv.2025.101832.
2
Prevalence and Management of Multiple Valvular Heart Disease in Patients Undergoing Transcatheter Aortic Valve Replacement: A Multicenter Study on the Impact of Staged Valvular Interventions on Outcomes.经导管主动脉瓣置换术患者中多瓣膜心脏病的患病率及管理:关于分期瓣膜干预对结局影响的多中心研究
J Am Heart Assoc. 2025 Jun 17;14(12):e040150. doi: 10.1161/JAHA.124.040150. Epub 2025 Jun 5.
3
Beta-blockers in patients without heart failure after myocardial infarction.心肌梗死后无心力衰竭的患者使用β受体阻滞剂。
Cochrane Database Syst Rev. 2021 Nov 5;11(11):CD012565. doi: 10.1002/14651858.CD012565.pub2.
4
Does Augmenting Irradiated Autografts With Free Vascularized Fibula Graft in Patients With Bone Loss From a Malignant Tumor Achieve Union, Function, and Complication Rate Comparably to Patients Without Bone Loss and Augmentation When Reconstructing Intercalary Resections in the Lower Extremity?对于因恶性肿瘤导致骨缺损的患者,在重建下肢节段性切除时,采用带血管游离腓骨移植来增强照射后的自体骨移植,其骨愈合、功能及并发症发生率与无骨缺损且未进行增强的患者相比是否相当?
Clin Orthop Relat Res. 2025 Jun 26. doi: 10.1097/CORR.0000000000003599.
5
Systemic pharmacological treatments for chronic plaque psoriasis: a network meta-analysis.慢性斑块状银屑病的全身药理学治疗:一项网状荟萃分析。
Cochrane Database Syst Rev. 2017 Dec 22;12(12):CD011535. doi: 10.1002/14651858.CD011535.pub2.
6
Antiepileptic drug monotherapy for epilepsy: a network meta-analysis of individual participant data.抗癫痫药物单药治疗癫痫:一项个体参与者数据的网络荟萃分析。
Cochrane Database Syst Rev. 2022 Apr 1;4(4):CD011412. doi: 10.1002/14651858.CD011412.pub4.
7
Smoking cessation for secondary prevention of cardiovascular disease.戒烟对心血管疾病二级预防的作用。
Cochrane Database Syst Rev. 2022 Aug 8;8(8):CD014936. doi: 10.1002/14651858.CD014936.pub2.
8
Effects of a gluten-reduced or gluten-free diet for the primary prevention of cardiovascular disease.减少或无麸质饮食对心血管疾病一级预防的影响。
Cochrane Database Syst Rev. 2022 Feb 24;2(2):CD013556. doi: 10.1002/14651858.CD013556.pub2.
9
Optimisation of chemotherapy and radiotherapy for untreated Hodgkin lymphoma patients with respect to second malignant neoplasms, overall and progression-free survival: individual participant data analysis.未治疗的霍奇金淋巴瘤患者化疗和放疗在第二原发性恶性肿瘤、总生存期和无进展生存期方面的优化:个体参与者数据分析
Cochrane Database Syst Rev. 2017 Sep 13;9(9):CD008814. doi: 10.1002/14651858.CD008814.pub2.
10
Systemic pharmacological treatments for chronic plaque psoriasis: a network meta-analysis.系统性药理学治疗慢性斑块状银屑病:网络荟萃分析。
Cochrane Database Syst Rev. 2021 Apr 19;4(4):CD011535. doi: 10.1002/14651858.CD011535.pub4.

本文引用的文献

1
Treatment patterns and trajectories in patients after acute heart failure hospitalization.急性心力衰竭住院患者的治疗模式和轨迹。
ESC Heart Fail. 2024 Apr;11(2):692-701. doi: 10.1002/ehf2.14635. Epub 2023 Dec 14.
2
Tricuspid Valve Academic Research Consortium Definitions for Tricuspid Regurgitation and Trial Endpoints.三尖瓣学术研究联合会关于三尖瓣反流和试验终点的定义。
J Am Coll Cardiol. 2023 Oct 24;82(17):1711-1735. doi: 10.1016/j.jacc.2023.08.008. Epub 2023 Oct 4.
3
Association of pre-hospital precipitating factors with short- and long-term outcomes of acute heart failure patients: A report from the WET-HF2 registry.
院前诱发因素与急性心力衰竭患者短期和长期结局的相关性:来自 WET-HF2 注册研究的报告。
Int J Cardiol. 2023 Oct 15;389:131161. doi: 10.1016/j.ijcard.2023.131161. Epub 2023 Jul 10.
4
Association of Tricuspid Regurgitation With Outcome in Acute Heart Failure.三尖瓣反流与急性心力衰竭结局的关系。
Circ Cardiovasc Imaging. 2023 Jul;16(7):566-576. doi: 10.1161/CIRCIMAGING.122.014988. Epub 2023 Jun 29.
5
Transcatheter Repair for Patients with Tricuspid Regurgitation.经导管三尖瓣反流修复术治疗患者。
N Engl J Med. 2023 May 18;388(20):1833-1842. doi: 10.1056/NEJMoa2300525. Epub 2023 Mar 4.
6
Prognostic implications of atrial vs. ventricular functional tricuspid regurgitation.三尖瓣瓣中瓣介入治疗的临床研究进展
Eur Heart J Cardiovasc Imaging. 2023 May 31;24(6):733-741. doi: 10.1093/ehjci/jead016.
7
Phenotyping of Elderly Patients With Heart Failure Focused on Noncardiac Conditions: A Latent Class Analysis From a Multicenter Registry of Patients Hospitalized With Heart Failure.老年心力衰竭患者表型分析侧重于非心脏疾病:一项来自心力衰竭住院患者多中心登记的潜在类别分析。
J Am Heart Assoc. 2023 Feb 7;12(3):e027689. doi: 10.1161/JAHA.122.027689. Epub 2023 Jan 25.
8
Evolution of tricuspid regurgitation after transcatheter edge-to-edge mitral valve repair for secondary mitral regurgitation and its impact on mortality.经导管缘对缘二尖瓣修复术治疗继发性二尖瓣反流后三尖瓣反流的演变及其对死亡率的影响。
Eur J Heart Fail. 2022 Nov;24(11):2175-2184. doi: 10.1002/ejhf.2637. Epub 2022 Aug 16.
9
Association between class of foundational medication for heart failure and prognosis in heart failure with reduced/mildly reduced ejection fraction.心力衰竭伴射血分数降低/轻度降低患者基础心衰药物类别与预后的关系。
Sci Rep. 2022 Oct 5;12(1):16611. doi: 10.1038/s41598-022-20892-3.
10
Atrial Functional Tricuspid Regurgitation: Novel Definition and Impact on Prognosis.三尖瓣功能性反流:新定义及其对预后的影响。
Circ Cardiovasc Interv. 2022 Sep;15(9):e011958. doi: 10.1161/CIRCINTERVENTIONS.122.011958. Epub 2022 Sep 20.